Navigation Links
Dyadic International To Announce Second Quarter 2014 Financial Results And Host Conference Call On Thursday, August 14, 2014
Date:8/1/2014

JUPITER, Fla., Aug. 1, 2014 /PRNewswire/ -- Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a global biotechnology company whose patented and proprietary technologies are used to develop, manufacture and sell enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, announced today that it will report its financial results for the second quarter ended June 30, 2014 after market close on Thursday, August 14, 2014 and will host a conference call that day at 5:00 p.m. Eastern Time to discuss those results.

(Logo: http://photos.prnewswire.com/prnh/20110621/CL06708LOGO )

In order to participate in the live session, please use the following dial-in numbers five to ten minutes prior to start time:

Calling from the United States or Canada:  888-596-2611

Calling from other countries:  913-981-5559

Confirmation Code:  1132588

A replay of the conference call will be available on Dyadic's website (www.dyadic.com) within 24 hours after the live event.

About Dyadic

Dyadic International, Inc. is a global biotechnology company that uses its patented and proprietary technologies to conduct research, development and commercial activities for the discovery, development, manufacture and sale of enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries. Dyadic utilizes an integrated technology platform based on its patented and proprietary C1 microorganism, which enables the development and large scale manufacture of low cost enzymes and other proteins for diverse market opportunities. The C1 platform technology can also be used to screen for the discovery of novel genes. In addition to the sale of proprietary enzyme products, Dyadic actively pursues licensing arrangements and other commercial opportunities to leverage the value of these technologies by providing its partners and collaborators with the benefits of manufacturing and/or utilizing the enzymes and other proteins which these technologies help produce.  Please visit Dyadic's website at www.dyadic.com.  Dyadic trades on the OTCQX tier of the OTC marketplace. Investors can find real-time quotes, market information and financial reports for Dyadic on the OTC marketplace website at www.otcmarkets.com/stock/DYAI/quote.

Cautionary Note Regarding Forward-Looking Statements

Certain statements contained in this press release are forward-looking statements within the meaning of the federal securities laws. These forward-looking statements involve risks, uncertainties and other factors that could cause Dyadic's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Investors are urged to consider these factors carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements. Any forward-looking statements speak only as of the date of this press release and, except as required by law, Dyadic expressly disclaims any intent or obligation to update or revise any forward-looking statements to reflect actual results, any changes in expectations or any change in events. Factors that could cause results to differ materially include, but are not limited to: (1) general economic conditions, including the recent conditions in the global markets; (2) Dyadic's ability to retain and attract employees; (3) competitive pressures and reliance on key customers and collaborators; (4) Dyadic's research and development efforts, (5) the outcome of the current litigation by Dyadic against its former counsel and (6) other factors discussed in Dyadic's publicly available filings, including the risk factors included in Dyadic's Annual Report filed with the OTC Markets Group on March 31, 2014.


'/>"/>
SOURCE Dyadic International, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Dyadic Netherlands To Develop Enzymes For EU-Funded Research Consortium
2. Dyadic International To Announce Third Quarter 2012 Financial Results And Host Conference Call On Thursday, November 8, 2012
3. Dyadic International Reports Profitable 2012 Full Year Financial Results
4. Dyadic International Extends All Debt Maturity Dates
5. New U.S. Patent Issued To Dyadic International
6. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
7. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
8. Latest Findings in Breastfeeding Science Presented at Medelas 7th International Breastfeeding and Lactation Symposium
9. SurgLine International, Inc. Launches A Wholly Owned Operating Subsidiary To Pursue Cost Containment Strategies
10. International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets.
11. Chindex International, Inc. to Report First Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... 28, 2016   Acsis , a leading provider ... IT market research and advisory firm IDC has named ... MarketScape: Worldwide Pharmaceutical Track and Trace Software 2016 Vendor ... an assessment of the capabilities and business strategies of ... market. Logo - http://photos.prnewswire.com/prnh/20160427/360791LOGO ...
(Date:4/27/2016)... Inc. (Nasdaq: HOLX ) announced today ... quarter ended March 26, 2016.  GAAP diluted earnings ... non-GAAP diluted EPS of $0.47 increased 14.6%.  Revenue ... basis, and 6.3% on a constant currency basis.  ... highlighted by 14.6% growth in non-GAAP EPS," said ...
(Date:4/27/2016)... , April 27, 2016 ... accelerator (MR-linac) platform will be the focal point of ... of the European Society for Radiotherapy & Oncology, taking ... MR-linac integrates a state-of-the-art radiotherapy system and a high-field ... to clearly see the patient,s anatomy in real time. ...
Breaking Medicine Technology:
(Date:5/2/2016)... ... May 02, 2016 , ... Advanced Spine ... fluid/“stem cells” and Platelet Rich Plasma (PRP) injections. “These are becoming the ‘go-to’ ... Baranski, D.C., of Advanced Spine & Sport Medical. “We are very excited to ...
(Date:5/1/2016)... ... May 01, 2016 , ... Women's Excellence in Wellness, powered ... taught by Patti Dolan, a Young Living Gold Member. , The class will be ... followed by a small intro to the Oils that can benefit participant's yoga practice, ...
(Date:5/1/2016)... ... 2016 , ... ProBrand Reveal Volume 2 is a set of versatile and smooth logo reveals ... animations, users can easily create a unique logo reveal in just a matter of minutes. ... Use these title presets to add a uniquely animated logo to any photos or videos. ...
(Date:5/1/2016)... ... May 01, 2016 , ... Good Circle Insurance Agency ... of chiropractic help. The agency offers a verity of health, life and injury policies ... to Chris Nelson at the firm, “Many insurance plans don’t cover chiropractic care, so ...
(Date:4/30/2016)... ... April 30, 2016 , ... Create an abstract shape animation ... and manipulate three-dimensional shapes with ease all within Apple Motion . Users ... polygon texture animation, opacity texture animation, overall shape texture displacement, twist, camera controls, ...
Breaking Medicine News(10 mins):